About the Company
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $LGND News
Q4 2023 Ligand Pharmaceuticals Inc Earnings Call
Ladies and gentlemen, thank you for standing by, and welcome everyone to the Ligand Fourth Quarter 2023 earnings webcast. At this time, all lines have been placed on mute to prevent any background ...
Ligand Pharmaceuticals Inc Q4 Earnings Summary
(RTTNews) - Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND): Earnings: $18.19 million in Q4 vs. -$17.49 million in the same period last year. EPS: $1.03 in Q4 vs.
Ligand: Q4 Earnings Snapshot
SAN DIEGO — SAN DIEGO — Ligand Pharmaceuticals Inc. (LGND) on Tuesday reported net income of $18.2 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had ...
Ligand Pharmaceuticals Inc (LGND) Reports Solid Earnings Amidst Operational Transformation
Warning! GuruFocus has detected 6 Warning Signs with LGND. Ligand Pharmaceuticals Inc (NASDAQ:LGND) released its 8-K filing on February 27, 2024, detailing its financial results for the fourth ...
Ligand Pharmaceuticals Inc. (LGND) Q4 2023 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome everyone to the Ligand Fourth Quarter 2023 Earnings Webcast. At this time, all lines have been placed on mute to prevent any background noise.
Ligand Pharmaceuticals Inc LGND
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Q4 2023 Ligand Pharmaceuticals Inc Earnings Call
Ladies and gentlemen, thank you for standing by, and welcome everyone to the Ligand Fourth Quarter 2023 earnings webcast ... Rylaze is marketed by our partner, Jazz Pharmaceuticals as a component of a ...
Loading the latest forecasts...